Archives
- November 2008 (807)
- October 2008 (1444)
- September 2008 (1352)
- August 2008 (1298)
- July 2008 (1684)
- June 2008 (1646)
- May 2008 (1813)
- April 2008 (945)
- March 2008 (1892)
- February 2008 (1532)
- January 2008 (1)
- January 1970 (1)
Blogroll
- GigaOM » Web - The Business of Technology
- Go2Web20.net - A wall of logos of the latest web 2.0 applications. Find what you need. Discover what you don't...
- KillerStartups.com - all - KillerStartups.com
- Mashable! - Social software and social networking 2.0.
- VentureBeat - Silicon Valley news about tech money and innovation
After I and Inquisitr’s Duncan Riley yesterday both expressed a bit of apprehension that the sometimes unscrupulous world of affiliate and MLM marketing might be making its way to the Twittersphere, John Reese (founder of traffic funnelling pyramid scheme BlogRush) decided to “set the record straight” on his personal blog. Unfortunately for John, much like in his marketing verbiage, he was unable to stay very far away from hyperbole and the ridiculous allegation that I didn’t research my position before I promoted it.
Of the many things that John took issue with, the first thing he mentioned was that both Duncan and I didn’t do our research. As evidence of this, he bragged that he’d “never sold an ebook since I’ve been marketing online for over 15 years.” I stand corrected on this point. He gave away ebooks to sell “digital home study materials.“ Essentially, books on CD. Not ebooks, per se, but pretty close.
Most of the rest of his post, in retort, reads like the marketing verbiage you probably remember from BlogRush and from the excerpts of his Twitter letter Duncan and I quoted. “I’m the best,” and “I’ve made high traffic sites,” and “I made all this money, and it was only my side project.” I’m sure that impresses a lot of folks, otherwise how else would have have sold all his “not-ebooks.” His defenses of his actions seem to amount to “I’m rich, so I’m right.” Bank robbers can be rich, too. That doesn’t make them right either.
His thrust of his retorts seem to be that I’m some sort of anti-marketing hippie, and that my “lack of research” is a thorough indication that something is rotten in the state of Mashable (or perhaps even blogging entirely?). Anyone that has followed my opinion pieces in general, or who actually knows me, knows this is laughable, as I’ve many times defended marketing from undue government regulation and attack. What I (and most human beings, for that matter) hate with a passion are hucksters trying to pawn off on me something I don’t need or have any use or interest in. This is something in which, unfortunately, the affiliate marketing world excels in. That isn’t an indictment of everyone who might be an affiliate marketer, but it is an indictment of a lot of the more visible members of this demographic.
I know of what I speak, on this. Many years ago, I was a CTO at a credit assistance agency that employed affiliate marketing techniques for a time to grow the business. As such, I learned more than I ever wanted to know about the MLM world, but was afraid to ask. I could describe my experiences there in detail, but the best analogy I can provide to you as to how the MLM and affiliate marketing world works is to liken it to a spyware infection.
When you’re infected by one piece of spyware, it often opens the floodgates for a host of other virus, malware and spyware infections. Similarly, you talk to one affiliate marketer, who may be a decent guy and wants to sell you something you need or sell something for you. Unfortunately, just by talking to that one fellow, it seems you soon have (no exaggeration) have hundreds of marketers beating down your door and flooding your inbox with ridiculous offers, pie-in-the-sky schemes, get-rich-quick scams and often outlandish conspiracy theories.
(Imagine that for a moment, and amplify it through the megaphone of Twitter-mania. Twitter could get really unbearable while affiliate marketers infiltrate, amass hordes of followers, and start trying to sell their ebooks on ways to infiltrate twitter, amass hordes of followers and sell ebooks on …. )

John notes my extreme dissatisfaction with BlogRush in his response to me, and promises me a full refund for my investment (a clever distraction of a promise, since the widget and “service” was free). He then goes on to boast that the BlogRush service garners more traffic than Mashable. His defense is to intimate that there was no harm done by hoodwinking thousands of bloggers into installing a useless widget. It’s true that no actual money was lost, but it doesn’t make it right, valuable to anyone (other than John and his team), or even honest.
At the end of the day, I’m still a fan of marketing (contrary to the laughable claims of John Reese’s groupies of me being a socialist), but that doesn’t have to make me a fan of John Reese. While his moves may have made him rich, nothing I’ve seen in his past shows me that he’s done much to separate himself from the shadier marketers in the very same space as him. Despite his claims to the contrary, nothing on the public record (read: researchable) shows that he’s a trustworthy member of the social media community at large (particularly since his defense of himself was full of truth-twisting and hyperbole). In the end, it is that which make me doubt his intentions aren’t to make Twitter part of some affiliate marketing scheme - something I nor anyone else is going to enjoy.
---
Related Articles at Mashable! - The Social Networking Blog:
Is Twitter Vulnerable to Marketer Attack?
BlogRush: Phase 2 Brings the Blog; Still No Rush
Mozilla Names John Lilly as New CEO
John Oates Plays at DEMO
Did BlogRush Dump the Wrong 10,000 Bloggers?
John Howard’s YouTube Plea for Votes…Without a Video.
Will McCain Bore the Teens on MySpace and MTV?

The advent of Twitter going mainstream is upon us, according to Inquisitr’s Duncan Riley. That’s not actually how he put it, though. I believe he said something like “doom, gloom, and the end of days!”
What’s bringing this glorious/tragic event? Riley quotes an email he recieved from known Web 2.0 flopster and prolific e-book salesman John Reese:
If you haven’t yet created a Twitter account you’re really missing out.
This service has exploded in growth in the past few months and I don’t see it slowing down anytime soon. There are now MILLIONS of users and it’s becoming mainstream.
I’ve been running some interesting tests and I’m already seeing some great traffic results — far greater than the traffic from Facebook or any other “Web 2.0″ service.Facebook and the others certainly have their place, but Twitter is more powerful. At first I didn’t really “get it” but now I do and my traffic stats don’t lie. IT WORKS.
[..]
So trust me, this is no flash in the pan. In fact, this may be one of the most powerful marketing
tools ever — it just depends how it evolves.But so far you’d be crazy not to use it. It’s producing great results.
On the one hand, its hard to take much that John Reese says seriously after his outlandish claims landed a net negative with his service BlogRush. Given his propensity for hyperbole, I’m unsure exactly what he’s promising his victims e-book customers in the texts, but in a certain sense, he’s not wrong. When used in the manner it was intended, Twitter is a mighty powerful marketing tool. Even if John Reese makes claims that he can actually live up to this time, given that there are a million affiliate marketers with even less scruples, there will be a number of e-books to follow from several other folks trying to game the system.
Fortunately for those of us on Twitter currently, as studies plainly show, we’re nigh-immune to the shady tactics of those who would like to use the system for profit whilst at the same time adding no value. If these e-book marketers turn legit and realize this, we may have a group of highly effective evangelists carrying the gospel of Twitter to the masses. Or, conversely, we may have a group of unscrupulous jerks bringing in a load of undesirables for a little while (who will leave once they realize it isn’t profitable to try to game the system).
I’m can’t predict which. It could go either way.
---
Related Articles at Mashable! - The Social Networking Blog:
The Daily Poll: Would You Buy an eBook Reader?
Twitter Mobile Interface
Quick Fix For Twitter Troubles
Don’t Send Bac’n: Use TwitterSearch
Mosio Uses Twitter For Mobile Q&A
Twitter Adds GMail Contacts Import
How Messed Up Is Twitter For You Right Now? [Poll]
(UPDATED: See below.)
Getting stuff for free is always an attractive proposition from the consumer’s point of view, if not necessarily the greatest business model for the company doing the giving (go ahead and recall your favorite dot-com example here). Now TrialPay, a self-described arranger of “alternative payments” that just raised another $13 million, thinks it’s found a way to square that circle by updating an old department-store offer: Buy one, get one free.
TrialPay gets online vendors — many of them software makers who are painfully aware that few people really want to pay for their offerings anymore — to offer visitors a free product if they’ll sign into the TrialPay service and buy something from a list of selected, and presumably targeted, advertisers. Once the purchase is verified, TrialPay emails the consumer a coupon for their free swag. TrialPay has started to attract some well-known advertising merchants to its platform, ranging from brick-and-mortar stalwarts like Citibank, Geico, Comcast and Time Warner Cable to Web-centric businesses such as eBay, eBags and eMusic.
This is still one of those ideas that sounds kind of nutty until you dive into the business logic behind it. Essentially, the merchant who actually sells its product — the “buy one” side of the deal — is subsidizing its “get one free” counterpart in exchange for acquiring a new customer relatively cheaply. (The rationale is similar to that of merchants who pay bounties to blogs and other Web sites that deliver customers through affiliate programs.) That commission is often higher than the actual selling price of the free item, TrialPay says. And as long as the average customer buys more than an item or two, the selling company also makes money on the transaction. The New York Times explains it all in detail here.
TrialPay, which is based in Mountain View, Calif., makes money by taking a cut of the commission and supposedly also does some targeting to put the most relevant advertisers in front of would-be customers. The company told the NYT that roughly 2,500 merchants now show TrialPay offers to prospective customers and that its annual sales may top $20 million. (Presumably, TrialPay is referring to its own revenues and not the total sales volume moving through its network. I’ll run that down and update. UPDATE: A TrialPay spokesperson confirms that the company is expecting total revenue of more than $20 million in 2008.))
That said, TrialPay isn’t exactly intuitive the first time you come across it. Coincidentially enough, I ended up stumbling across a TrialPay site just yesterday while downloading a free version of the antispyware program Ad-Aware. First, TrialPay snags you as you’re about to launch the free download with an offer for a free copy of the paid version:

Next, you’re asked to sign into TrialPay with your name and email address. There’s a minimum of explanation here, and at the time, as someone who’d never heard of TrialPay before, some of the language here — especially, “Try it, it’s free” — struck me as a little on the hucksterish side. In fact, it was at this point that I bailed on TrialPay, particularly since I had no idea what I’d be signing up for and how much marketing spam I might inadvertently be opting into. (Yes, the signup box says your email address won’t be sold; I just didn’t believe it.) That screen is here:
Next, you’re presented with a variety of advertiser offers, which you can sort by category and even filter specifically for merchants who’ll give you instant credit for your purchases (some credits, particularly with big financial institutions, can take a few days). Here, for instance, is what the service offered me:
Whether such offers float your boat or not is a matter of personal preference. (I didn’t end up biting on any of them.) Overall, however, TrialPay offers a pretty intriguing model, and one that several of its participating merchants seem happy with. “You can reach out into the virtual space and find new customers you wouldn’t have otherwise reached,” Gap.com general manager Will Hunsinger told the NYT. “It’s a little different model, which is something we haven’t seen come out of the Valley in a little while.”
TrialPay just raised $12.7 million in a second funding round (the release is here), for a total of $15.8 million since its founding in 2006. Investors in the latest round included Index Ventures, Atomico Ventures and former PayPal executives.
about
SocialTake.com brings you the latest social networking and web 2.0 news from the most popular sources on the web.
categories
- $1 (2)
- $1000 genome (1)
- -Labels (2)
- 000 genome (2)
- 123people.com (1)
- 3i Group (1)
- a-la-mobile (1)
- Aber Whitcomb (1)
- Adaptive Blue (2)
- adcamo (2)
- Adobe (17)
- Adrian Si (1)
- affiliate marketing (3)
- AKAM (5)
- Amazon (34)
- AMZN (16)
- AOL (51)
- aortic valve (3)
- APIs (74)
- Apple (65)
- Ask (4)
- AT&T (11)
- Attention (5)
- Baidu (3)
- bebo (45)
- biogenerics (1)
- biotech chameleon (1)
- biotechnology (18)
- bleeding control (1)
- blogger (14)
- Blogging-Widgets (149)
- blogtv (1)
- BoulevardR (1)
- Broadband (75)
- bullpoo (1)
- Business and Technology (3333)
- buzzd (1)
- cake (1)
- Caligari (1)
- cardiovascular disease (1)
- cell therapy (1)
- Charter (3)
- China Mobile (1)
- CHTR (2)
- citizen journalism (27)
- CleanTech (443)
- Cleveland Clinic (1)
- cmcsa (6)
- co: covestor (1)
- co: crossbeam systems (3)
- co: HowCast (1)
- co: Kobalt (1)
- co: yahoo (1)
- co:23andme (2)
- co:abengoa solar (1)
- co:Accumetrics (1)
- co:adaptiveblue (4)
- co:adconion (2)
- co:Adobe (27)
- co:adura systems (1)
- co:aeria (1)
- co:agami systems (1)
- co:Alltracel Pharmaceuticals (1)
- co:amazon (51)
- co:aquantia (2)
- co:Arbor Surgical Technologies (3)
- co:Archemix (1)
- co:archetype media (1)
- co:Aricent (2)
- co:AT&T (54)
- co:Atrua Technologies (1)
- co:Audience (3)
- co:audience analytics (1)
- co:Ausra (6)
- co:Bioheart (2)
- co:Bleacher Report (1)
- co:Blist (1)
- co:boom entertainment (1)
- co:Bragster (1)
- co:Bunchball (1)
- co:capitalstream (1)
- co:Carbonite (2)
- co:CareSquare (1)
- co:Cellfire (1)
- co:Cequent Pharmaceuticals (1)
- co:change:healthcare (1)
- co:CNET (9)
- co:cogent wireless (1)
- co:Collarity (1)
- co:comedy.com (1)
- co:comscore (7)
- co:Cool Earth Solar (1)
- co:covega (1)
- co:Coverity (2)
- co:dakim (1)
- co:Danger (1)
- co:Dealipedia (1)
- co:DesignArt Networks (1)
- co:Digsby (1)
- co:dizzywood (1)
- co:DoubleTwist (1)
- co:duels (1)
- co:earth eternal (3)
- co:EKR Therapeutics (1)
- co:emotiv (1)
- co:Facebook (173)
- co:federated media (1)
- Co:Fliqz (3)
- co:forrester (1)
- co:Fox (7)
- co:futuregen (2)
- co:Gannett Company (1)
- co:gemfire (1)
- co:genietown (1)
- co:Glam (16)
- co:GlobalLogic (1)
- co:google (311)
- co:graffiti (1)
- co:Greenplum (3)
- co:GumGum (4)
- co:hcl technologies (1)
- co:Hearst Corporation (1)
- co:HemCon Medical Technologies (1)
- co:Hewlett Packard (1)
- co:HotorNot (1)
- co:iLike (5)
- co:iMeem (13)
- co:iminlikewithyou (2)
- co:Infinia (2)
- co:Infospace (1)
- co:Innotek (1)
- co:Insilica (1)
- co:Integrated Media Holdings (1)
- co:ivideosongs (1)
- co:Kindo (1)
- co:KnockaTV (1)
- co:Kotura (1)
- co:Laszlo Systems (1)
- co:like.com (4)
- co:LinkedIn (26)
- co:linux networx (1)
- co:LiveUniverse (1)
- co:loglogic (1)
- co:Lookery (5)
- co:lotame (2)
- co:lumenergi (1)
- co:Magnify.net (3)
- co:martha stewart living omnimedia (1)
- co:maven networks (1)
- co:Metaplace (2)
- co:microsoft (279)
- co:miles electric vehicle (2)
- co:mochi media (1)
- co:Mohr Davidow Ventures (1)
- co:montalvo systems (1)
- co:Motricity (1)
- co:Mozilla (20)
- co:MySpace (68)
- co:Mywaves (2)
- co:nabbr (1)
- co:NeoEdge (1)
- co:NetMagic Solutions (1)
- co:neurosky (1)
- co:Nielsen (3)
- co:nintendo (54)
- co:nokia (22)
- co:Novell (1)
- co:NuConomy (2)
- co:Numenta (3)
- co:Numerate (1)
- co:Ocera Therapeutics (1)
- co:oDesk (2)
- co:OraMetrix (1)
- co:Outbrain (2)
- co:overlay.tv (1)
- co:Pacific Biosciences (3)
- co:PBWiki (1)
- co:PDL BioPharma (1)
- co:peanut labs (1)
- co:Pentaho (1)
- co:Pharmix (1)
- co:pliant technology (1)
- co:publicearth (1)
- co:pythagoras solar (1)
- co:Quark Pharmaceuticals (1)
- co:Quigo (1)
- co:Quintic (1)
- co:radar networks (2)
- co:raptr (2)
- co:ravenflow (1)
- co:Renkoo (1)
- co:Revver (2)
- co:rmbr (4)
- co:Rocketon (2)
- co:Scribd (3)
- co:seatwave (1)
- co:seesmic (11)
- co:SellPoint (1)
- co:sequans (1)
- co:sgi (1)
- co:Silence Therapeutics (1)
- co:Sitescape (1)
- co:SkyRider (2)
- co:smashwords (1)
- co:Snocap (2)
- co:social gaming network (2)
- co:Solicall (2)
- co:sony (76)
- co:sparkplay media (3)
- co:stormfisher (1)
- co:Sub One Technology (1)
- co:Sun (6)
- co:Surf Canyon (1)
- co:tehuti networks (1)
- co:TeleChem International (1)
- co:Teranetics (1)
- co:Tesla Motors (2)
- co:The New York Times Company (1)
- co:TheFunded (7)
- co:TherOx (1)
- co:Thisnext (1)
- co:TrialPay (1)
- co:Tribune Company (1)
- co:TurnHere (1)
- co:twine (5)
- co:twofish elements (1)
- co:tzero technologies (1)
- co:Ubicom (1)
- co:Ulocate (1)
- co:Ustream.tv (1)
- co:uvlayer (1)
- co:vaultus mobile technologies (1)
- co:venturebeat (4)
- co:Verizon (17)
- co:vestopia (1)
- co:vobile (1)
- co:vois (1)
- co:Vonage (2)
- co:voxify (1)
- co:Wal Mart (2)
- co:Webalo (1)
- co:weddingwire (1)
- co:WikiLeaks (2)
- co:WooMe (2)
- co:Xcerion (2)
- co:XinLab (1)
- co:xobni (6)
- co:xpree (1)
- co:xuqa (1)
- co:Younoodle (2)
- co:YouTube (46)
- co:zinga (1)
- co:Zonare Medical Systems (1)
- co:zync (1)
- co:zynga (5)
- Comcast (21)
- Comm (101)
- Contributors (24)
- crime (2)
- DEADPOOL (2)
- deal (523)
- Dell (9)
- DEMO (4)
- demo account (1)
- diagnostics (8)
- digg (68)
- dizzywood (1)
- drug engineering (1)
- drug re acquisition (1)
- e commerce (1)
- earnings (1)
- eBay (17)
- eCommerce (357)
- Ed Markey (5)
- education (11)
- electronic medical records (3)
- emc (4)
- Eric Schlissel (1)
- Events (256)
- EVRI (1)
- facebook (398)
- FDA (1)
- Featured (58)
- FLAG Telecom (1)
- Freebase (1)
- Garmin (4)
- Geezeo (2)
- gene chips (1)
- gene sequencing (1)
- genome sequencing (2)
- genomics (4)
- GOOG (75)
- Google (483)
- Google Gears (5)
- Google Health (5)
- google-docs (1)
- Google-News (2)
- googlevideo (11)
- gphone (6)
- GRMN (1)
- health 2.0 (9)
- healthcare reform (1)
- heart attack (1)
- Helio (1)
- heroku (1)
- hi5 (24)
- HIPAA (1)
- Howcast (2)
- Hybrid Apps (1)
- ibm (5)
- IDC (2)
- IDG (2)
- IDG Ventures (1)
- Infrastructure (39)
- Interpolls (1)
- Intuit (1)
- inv (1)
- inv: matrix partners (3)
- inv:3i Group (1)
- inv:accel partners (2)
- inv:Adams Street partners (1)
- inv:Adinvest (2)
- inv:Adobe Ventures (1)
- inv:Advanced Equities (1)
- inv:Advanced Technology Ventures (1)
- inv:alcatel lucent (1)
- inv:Alloy Ventures (2)
- inv:Alloy Ventures (2)
- inv:Alloy Ventures (2)
- inv:Alta Partners (2)
- inv:Ambient Sound Investments (1)
- inv:Amicus Capital (1)
- inv:Ampersand Ventures (1)
- inv:Angeleno Group (2)
- inv:apex venture partners (1)
- inv:Arnerich Massena & Associates (1)
- inv:Ascension Health Ventures (1)
- inv:Atlas Venture (1)
- inv:Atomico Investments (1)
- inv:Atomico Ventures (1)
- inv:Balderton Capital (1)
- inv:bank of america (1)
- inv:Battery Ventures (1)
- inv:Bay Partners (2)
- inv:BB Biotech Ventures (1)
- inv:BBT Fund (1)
- inv:benaroya capital (1)
- inv:Benchmark (4)
- inv:Benchmark capital (3)
- inv:Bessemer Venture Partners (1)
- inv:betaworks (4)
- inv:Bluerun Ventures (2)
- inv:Brentwood Venture Capital (1)
- inv:Burda (1)
- inv:BV Capital (1)
- inv:Carmel Ventures (1)
- inv:CB Health Ventures (1)
- inv:charles river ventures (2)
- inv:Chevron Technology Ventures (1)
- inv:CMEA (1)
- inv:Columbia Capital (1)
- inv:Common Angels (1)
- inv:ComVentures (2)
- inv:Crossbow Equity Partners (1)
- inv:D.E. Shaw Group (1)
- inv:Delphi Ventures (1)
- inv:Delphi Ventures (1)
- inv:Delphi Ventures (1)
- inv:denham capital (1)
- inv:DFJ Frontier (1)
- inv:Domain Associates (1)
- inv:Draper Fisher Jurvestson (1)
- inv:Draper Fisher Jurvetson (2)
- inv:Draper Richards (1)
- inv:duff ackerman goodrich (1)
- inv:Earlybird (2)
- inv:El Dorado Ventures (2)
- inv:epicure capital partners (1)
- inv:equus total returns (1)
- inv:Ericsson Venture Partners (1)
- inv:Essex Woodland Health Ventures (1)
- inv:Evergreen Venture Partners (1)
- inv:Fidelity International Limited (1)
- inv:Fidelity Ventures (1)
- inv:Flextronics International (2)
- inv:Focus Ventures (1)
- inv:Foundation Capital (2)
- inv:Founders Fund (1)
- inv:Four River Partners (1)
- inv:Frazier Healthcare Ventures (1)
- inv:Frazier Technology Ventures (1)
- inv:FTVentures (6)
- inv:Galen Partners (1)
- inv:ge energy financial services (1)
- inv:gemini israel funds (2)
- inv:General Catalyst Partner (1)
- inv:GF Private Equity (1)
- inv:GlenRock Israel (1)
- inv:glg partners (1)
- inv:Global Catalyst Partners (1)
- inv:Granite Global Ventures (1)
- inv:Granite Ventures (2)
- inv:greylock partners (2)
- inv:Harbinger Venture Management (1)
- inv:hillcrest management (1)
- inv:Hillsven Capital (1)
- inv:Horsley Bridge (1)
- inv:hurst corporation (1)
- inv:Idealab (3)
- inv:IDG VC (1)
- inv:idg ventures (1)
- inv:Index Ventures (4)
- inv:Integral Capital Partners (1)
- inv:Intel Capital (7)
- inv:Invesco Private Capital (1)
- inv:Israel Cleantech Ventures (1)
- inv:itochu corporation (1)
- inv:jana partners (1)
- inv:JC6 (1)
- inv:Kaiser Permanente Ventures (1)
- inv:KB Partners (1)
- inv:Keiretsu Forum (1)
- inv:Kennelpoint (1)
- inv:Khosla Ventures (6)
- inv:kleiner perkins (4)
- inv:Kleiner Perkins Caufield & Byers (1)
- inv:Kohlberg Kravis Roberts & Co. (1)
- inv:Laguna Fund (1)
- inv:Laguna Fund (1)
- inv:Laguna Fund (1)
- inv:Leapfrog Ventures (2)
- inv:Lehman Brothers Venture Partners (1)
- inv:Lightspeed Venture Partners (5)
- inv:low carbon accelerator (1)
- inv:Magma Venture Partners (1)
- inv:mangrove capital (1)
- inv:Mangrove Capital Partners (2)
- inv:Maveron Equity Partners (1)
- inv:Maxtrix Partners (1)
- inv:Mayfield (4)
- inv:Menlo Ventures (4)
- inv:Merck KGaA (1)
- inv:merrill lynch (1)
- inv:Merrill Lynch Venture Capital (1)
- inv:Mitsui & Co. Venture Partners (1)
- inv:Mobius Venture Capital (1)
- inv:MobiusVC (1)
- inv:Mohr Davidow Ventures (3)
- inv:Morgenthaler Ventures (2)
- inv:Mosaix Ventures (1)
- inv:Motorola (2)
- inv:Motorola Ventures (1)
- inv:MySQL (1)
- inv:natixis (1)
- inv:NEA IndoUS Ventures (1)
- inv:NeoCarta Ventures (2)
- inv:New Atlantic Ventures (1)
- inv:New Enterprise Associates (6)
- inv:new frontier renewable energy (1)
- inv:New Science Ventures (1)
- inv:Nexus India Capital (1)
- inv:Nexus Medical Partners (1)
- Inv:Nokia Venture Partners (1)
- inv:nomura international (1)
- inv:Northern Light Venture Capital (1)
- inv:Novartis Option Fund (1)
- inv:noventi (2)
- inv:Ofer Hi Tech (1)
- inv:OVP Venture Partners (1)
- inv:Palomar Ventures (2)
- inv:Pappas Ventures (1)
- inv:Pinnacle Ventures (4)
- inv:Pitango Venture Capital (1)
- inv:Point Judith Capital (1)
- inv:Polaris Venture Partners (2)
- inv:polaris venture patners (1)
- inv:Power Play Energy (1)
- inv:Prism VentureWorks (3)
- inv:proseed venture capital fund (1)
- inv:PTV Sciences (1)
- inv:Quilvest Ventures (1)
- inv:Red Hat (1)
- inv:Redpoint Ventures (4)
- inv:reliance technology ventures limited (1)
- inv:Rho Capital Partners (1)
- inv:RiverVest (1)
- inv:Rockley Ventures (1)
- inv:roda group (1)
- inv:Rustic Canyon Ventures (1)
- inv:saints (1)
- inv:Samsung Ventrue INvestment Corporation (1)
- inv:Sequoia Capital (3)
- inv:Sequoia Capital India (1)
- inv:Shanghai Hua Hong International (1)
- inv:Sigma Partners (1)
- inv:Silver Creek Ventures (1)
- inv:Sofinnova Ventures (1)
- inv:Spark Capital (2)
- inv:Star Ventures (1)
- inv:Steamboat Ventures (1)
- inv:Storm Ventures (2)
- inv:Susquehanna International Group (1)
- inv:Swisscom (1)
- inv:Tallwood Venture Capital (1)
- inv:Technology Venture Partners (1)
- inv:TeleSoft Partners (1)
- inv:Texas Instruments (1)
- inv:tif ventures (1)
- inv:U.S. Venture Partners (2)
- inv:Union Square Ventures (1)
- inv:US Venture Partners (2)
- inv:valor equity partners (1)
- inv:Velocity Interactive Group (4)
- inv:Venrock (15)
- inv:venture tech alliance (1)
- inv:Versant Ventures (1)
- inv:Viterbi Group (1)
- inv:Voyager Capital (1)
- inv:vulcan (1)
- inv:Vulcan Capital (1)
- inv:Walden International (1)
- inv:Walden VC (1)
- inv:Wexford Capital (1)
- inv:WI Harper Group (1)
- inv:William Randolph Hearst III (1)
- inv:WorldView Technology Partners (1)
- inv:WPP (4)
- inv:Zimbra (1)
- iPaper (3)
- iPhone (134)
- IPO (10)
- IPO withdrawal (4)
- Issuu (2)
- Jerry Yang (5)
- justin.tv (6)
- KEvin Johnson (1)
- life sciences (3)
- lifesciences (50)
- linkedin (29)
- Lists (263)
- lunarr (2)
- M&A (3)
- M&A (3)
- M&A (3)
- Marketing (166)
- marketocracy (1)
- mashable (1159)
- matt Hulett (1)
- Media (48)
- medical devices (9)
- medical imaging (1)
- microarrays (1)
- Microshoo (24)
- Microsoft (155)
- Microsoft Yahoo (35)
- Mint (5)
- mixx (5)
- Mobile (218)
- Mobile 2.0 (292)
- mogulus (1)
- MOT (3)
- Motorola (4)
- Mozilla Prism (1)
- msft (40)
- myspace (293)
- myspace video (8)
- N (1)
- Net Neutrality (4)
- News (2557)
- News Corp (3)
- news-corp (1)
- Nortel (3)
- north bridge venture partners (3)
- Nova Spivack (1)
- Novarra (1)
- NT (3)
- Numobiq (1)
- NWS (2)
- oDesk (1)
- ONESite (1)
- oovoo (1)
- OpenID (8)
- Opinion (628)
- Opinion (628)
- Opinion (628)
- orkut (9)
- orthodontics (1)
- oxygen therapy (1)
- PaidContent (3)
- PeekYou (1)
- People Powered! (33)
- people: (1)
- people:Allen Morgan (1)
- people:Bill Ericson (2)
- people:Carl Icahn (1)
- people:Dan Finnigan (1)
- people:David Lawee (1)
- people:david weekly (1)
- people:Dean Takahashi (1)
- people:Dvd Jon (1)
- people:Elon Musk (1)
- people:Esther Dyson (1)
- people:Ford Tamer (1)
- people:gene mauro (1)
- people:Guido Lanza (1)
- people:james hong (1)
- people:jeremiah owyang (1)
- people:Jim Breyer (1)
- people:Joe Zhou (1)
- people:Jon Lech Johansen (1)
- people:Jonathan Miller (1)
- people:Keith Krach (1)
- people:Kevin Fong (1)
- people:Klaus Hommels (1)
- people:Lawrence Lessig (1)
- people:Lewis Cirne (1)
- people:Marc Benioff (1)
- people:Mark Zuckerberg (5)
- people:Max Levchin (1)
- people:Michael Robertson (1)
- people:Oliver Jung (1)
- people:owen van natta (1)
- people:Peter Thiel (1)
- people:philip balboni (1)
- people:Rajat Paharia (1)
- people:Redi Hoffman (1)
- people:Reed Hundt (1)
- people:Richard Branson (1)
- people:Rob Bearden (1)
- people:Robin Klein (1)
- people:Ron Conway (1)
- people:Tom Cole (1)
- people:Vikas Taneja (1)
- people:Yaron Galia (1)
- personal genomics (2)
- personal health records (3)
- personalized medicine (2)
- photobucket (13)
- podcast (35)
- politics (43)
- QCMM (1)
- QCOM (6)
- QuadrantOne (1)
- Qualcomm (7)
- Radar Networks (2)
- rational drug design (1)
- Reliance Telecom (1)
- Reuters (2)
- reverse merger (1)
- Revver (1)
- Rich Internet Apps (1)
- rimm (3)
- RNA interference (2)
- robotics (1)
- RockYou (8)
- Rupert Murdoch (2)
- S (6)
- Scion (1)
- Scribd (6)
- Search (726)
- Semiconductors (13)
- Sequans (1)
- Shorts (36)
- Slide (13)
- Slingshot Labs (1)
- social networking (1380)
- Social Platform (2)
- social software (349)
- SocialPicks (1)
- sohu (1)
- SPACs (2)
- special purpose acquisition companies (1)
- special purpose acquisition corporations (1)
- specialty pharmaceuticals (2)
- SpendView (1)
- Spock (1)
- Sprint (8)
- SRF (1)
- Startups (145)


